Navigation Links
New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years
Date:9/21/2010

ior. Depression assessments, as measured by the PHQ-9 clinical depression scale, improved from baseline for all treatment groups.

The incidence of targeted medical events for sleep disorders, depression, anxiety, cardiac disorders and cognitive disorders in SEQUEL was lower than observed during the one-year CONQUER study.

Similar to previously presented data, effects of QNEXA in SEQUEL on heart rate were small and seen in conjunction with improvements in blood pressure from baseline. There were no clinically relevant decreases of serum bicarbonate in QNEXA-treated patients compared to placebo in year two of SEQUEL.

Across the entire QNEXA development program (4,323 patients), including the two-year data in SEQUEL, serious cardiovascular and neurovascular adverse event rates in patients taking QNEXA were similar to placebo with a relative risk of 0.59 (95% CI: 0.33-1.06). No teratogenic effects were observed across the entire development program in patients taking QNEXA.

"These two-year data provide further reassurance that QNEXA may fill a significant medical need for this at-risk, co-morbid population struggling to lose weight and keep it off," said Leland Wilson, chief executive officer of VIVUS. "We look forward to presenting and publishing additional data from SEQUEL, including secondary efficacy endpoints for decreasing co-morbidity risks, in the future."

About QNEXA Controlled Release CapsulesQNEXA [kyoo-nek-suh] is an investigational drug being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which together decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2 and 3 clinical data to date, patients taking QNEXA have demonstrated statistically significant weight loss, glycemic control, and imp
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology
2. Partnership for Quality Medical Donations Commits to Long-Term Recovery in Haiti
3. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
4. FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
5. FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors
6. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
7. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
8. Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
9. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
10. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
11. Abbotts XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014   Lincor Inc. ... patient experience technology to New Jersey ... five-year agreement, CarePoint Health will deploy Lincor,s PatientLINC ... Center, Christ Hospital and Hoboken University Medical Center. ... range of software solutions to help hospitals reach ...
(Date:8/19/2014)... Ala. , Aug. 19, 2014  The Alabama Supreme ... that patients can sue drug makers who mislead doctors into ... harmful side‑effects.  The case is Weeks v. Wyeth, and the ... makers in that same case last year. Heninger Garrison Davis ... represent the patient in the case, Danny Weeks . ...
(Date:8/19/2014)... Aug. 19, 2014 Talyst, a market leader ... at the 2014 NPPA Summer Conference in ... showcasing its 340B software products and services.   ... solutions, supplying over 400 customers with a variety of ... solutions including its latest solution, AutoSplit® Contract Pharmacy and ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Talyst Exhibits at the NPPA Summer Conference 2
(Date:8/19/2014)... The elegant bamboo floorings from BambooIndustry.com are ... in an environmentally conscious way with the company’s floorings. ... have an aluminum oxide finish to help resist wear ... areas. , Recently, the company has released its new ... These fresh items are specially made for global customers. ...
(Date:8/19/2014)... As moms and dads prepare their children ... to the normal routine of dropping their little ones off ... MSc, RD encourages them to use the opportunity to ... , Yarker explains, “Kids have small tummies, short attention ... them junk food handouts, use snack time as another daily ...
(Date:8/19/2014)... 2014 BambooIndustry.com, a well-known bamboo product manufacturer ... deckings recently. The company is excited to reveal the ... special offer for all clients. Now, every customer can get ... will last until August 30. , The company’s deckings ... the world for supreme durability. They are perfect for a ...
(Date:8/19/2014)... Dentistry in Houston, Texas, is pleased to announce it is ... or with old fillings that need replacing, will benefit from ... restore teeth. , From now on any cavities will be ... completely amalgam free. Even though amalgam fillings have been deemed ... and children over the age of six, they do contain ...
(Date:8/19/2014)... Il (PRWEB) August 20, 2014 For ... allopathic medical world that chiropractic adjustments are dangerous and ... and this is why they do not recommend chiropractic ... more educated medical doctors do refer to chiropractors because ... However a statement regarding new research has popped up ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 3Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 4
... Shannon Malloy, critically injured in a car accident, skull separating ... call her recovery a miracle. ,A car ... her spine, although her skin, spinal cord and other internal ... internal decapitation, and it left her with no control over ...
... treatments. Since it is a very painful process, continuous attempts ... for the patient. ,Now researchers say that LHRH ... stop the production of a female hormone that encourages some ... action, often mimicking the action of a naturally occurring substance. ...
... and performance of other activities but as it turns out, ... ,This is the finding of a team of ... of Alberta. ,As a part study that was ... Canada, the researchers studied 24 patients, two-thirds of whom showed ...
... Moderate drinking may lower the risk of a type of ... ,The researchers at Brigham and Women's Hospital in ... of one alcoholic beverage a day were about 30 percent ... reduced risk they found in people who drank beer, wine ...
... towards making addition of folic acid to flour or bread mandatory ... disabilities. ,After lengthy public consultations the Food Standards ... its recommendations next month after it decides whether folic acid should ... ministers accept the FSA's proposals, it will be the first time ...
... a recent report, says that health specialists were able to ... the 2005 Bali bombings, thanks to improved procedures and services ... at the Royal Darwin Hospital who treated many of the ... health nurses. ,Says Anthony Guscott from Top End ...
Cached Medicine News:Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Chronic Pain can Impair Memory and Concentration 2Health News:UK too Will Insist on Folic Acid in Bread 2Health News:UK too Will Insist on Folic Acid in Bread 3Health News:Bali Bombings Helped Improve Trauma Care 2Health News:Bali Bombings Helped Improve Trauma Care 3
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Streck-Detergent IIIA is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured specifically for use on the Abbott CELL-DYN® 1700 and 1800. The s...
Medicine Products: